Canopy Growth, headquartered in Smiths Falls, Canada, is a prominent producer of medical and recreational cannabis, as well as hemp, through a diverse portfolio of brands including Tweed, Bedrocan Canada, Doja, and 7ACRES. The company operates over half a million square feet of indoor and greenhouse production capacity, allowing it to cultivate a wide variety of cannabis strains. In addition to its cannabis offerings, Canopy Growth also produces non-THC products such as skincare items under the Martha Stewart CBD brand and vaporizers through Storz & Bickel. The company has restructured its operations, merging its U.S. assets into a separately operated holding company, Canopy USA, which is not included in the financials of the Canadian entity.

Casa Verde Capital is a venture capital firm established in 2015 and based in Los Angeles, California. The firm specializes in seed investments within the cannabis industry, focusing specifically on ancillary businesses that do not directly handle the plant. This includes sectors such as agtech, health and wellness, financial services, technology, media, compliance, and laboratory technology. Casa Verde Capital aims to capitalize on what it views as one of the most compelling investment opportunities of the current generation, particularly within the evolving cannabis landscape in the United States. As a registered investment adviser, the firm seeks to support companies at various stages of development, from seed to later-stage investments.

OrganiGram Holdings Inc is a licensed producer of medical marijuana in Canada, operating under the Marihuana for Medical Purposes Regulations (MMPR). The company focuses on producing high-quality, indoor-grown cannabis for both medical patients and adult recreational consumers. OrganiGram has developed a diverse portfolio of recreational cannabis brands, including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, the company expanded its offerings to include Tremblant Cannabis and the artisanal craft brand Laurentian, enhancing its brand presence in the competitive cannabis market.

Gotham Green Partners is a private equity firm established in 2017, with offices in New York and Santa Monica, California. The firm specializes in investing in cannabis and cannabis-related enterprises, focusing on the entire cannabis value chain on a global scale. Gotham Green Partners manages a diversified investment portfolio and employs strategies such as buyouts and growth capital to support its investments. In addition to the cannabis sector, the firm also considers opportunities in healthcare services, consumer products, consumer services, and wellness, primarily within the United States and Canada. As a Registered Investment Adviser (RIA), Gotham Green Partners is committed to deploying capital effectively within these industries.

Merida Capital Holdings, established in 2009 and based in Rye, New York, is a private equity investment firm specializing in the cannabis sector. The firm targets growth opportunities related to cultivation technologies, as well as products and services that support the evolution of cannabis as an agricultural commodity, natural medicine, pharmaceutical ingredient, and recreational product. Merida Capital Holdings manages multiple funds with a focus on long-term investments, typically ranging from three to six years. It seeks to make impact investments in various sectors, including software, pharmaceuticals, biotechnology, and wellness, while emphasizing the agricultural and health sectors.

Poseidon Asset Management, LLC is an employee-owned hedge fund and venture capital investment firm based in San Francisco, California, founded in 2013. The firm focuses exclusively on the cannabis and hemp industries, managing pooled investment vehicles and separate client-focused portfolios. Poseidon employs fundamental, cyclical, and technical analysis to identify investment opportunities in sectors such as agtech, compliance technology, genetics and lab testing, industrial hemp, and data analytics. Committed to fostering responsible growth within the cannabis industry, Poseidon aims to challenge outdated perceptions of cannabis, advocating for its acceptance and working towards the end of cannabis prohibition. The firm seeks to invest in promising ventures, allowing investors to participate in the industry's expansion.

Privateer Holdings is a private equity firm based in Seattle, Washington, founded in 2010. It specializes in investments within the legal cannabis sector, focusing on incubation, seed funding, and venture capital across various stages of business development. The firm aims to shape the future of the cannabis industry by building a portfolio of global brands that promote the legitimacy and normalization of cannabis use. Its investments include notable companies such as Leafly, a leading cannabis information resource, Tilray, a significant producer of medical cannabis, and Marley Natural, the official cannabis and lifestyle brand associated with Bob Marley. With a commitment to ending cannabis prohibition, Privateer operates globally, leveraging its extensive experience in investment banking and venture capital.

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Navy Capital, founded in 2014 and based in New York, is a hedge fund manager that employs a research-oriented and fundamentally-driven investment strategy. The firm focuses on identifying attractive investment opportunities within the legal cannabis industry, targeting best-in-class businesses across key verticals such as consumer, healthcare, technology, industrials, and agriculture. By utilizing a long/short equity approach, Navy Capital aims to capitalize on the growth potential within these sectors while managing investment risks effectively.

Salveo Capital is a private equity and venture capital firm based in Northbrook, Illinois, founded in 2016. The firm specializes in direct investments across various stages, including seed, early, mid, late venture, and growth capital investments, as well as fund of fund strategies through limited partner interests in secondary markets. Salveo Capital primarily focuses on the legalized cannabis sector, particularly in ancillary markets such as software and data, financial services, agricultural technology, biotechnology, and licensing. The firm seeks to invest between $5 million and $10 million in companies that support or operate within the cannabis ecosystem, including cultivation centers, dispensaries, and related services. Salveo Capital aims to partner with entrepreneurs and management teams to build scalable businesses in this emerging industry, primarily targeting opportunities within the United States.

Phyto Partners is a venture capital firm established in 2015 and based in Boca Raton, Florida, specializing in early-stage investments within the cannabis industry across the United States. The firm provides essential capital to entrepreneurs and businesses that lack access to traditional funding sources. In addition to financial support, Phyto Partners leverages its extensive network of experienced executives, financial experts, and advisors to assist its portfolio companies with operational needs and strategic execution. The firm targets various sectors, including neurowellness, brain health, psychedelics, education, branded products, agricultural technology, point-of-sale software, advertising technology, and biotechnology, aiming to foster growth and innovation in these emerging markets.

Mystic Ventures is a venture capital firm established in 2021 and located in Los Angeles, California. The firm focuses on investing in the burgeoning fields of psychedelic medicine and research, driven by a belief in the therapeutic potential of psychedelics for mental health and human well-being. Mystic Ventures aims to support pre-seed and seed-stage startups that are developing innovative psychedelic treatments and experiences. By leveraging a vast network and expertise across various sectors, including academia and medicine, the firm is positioned to access a growing array of opportunities within this rapidly evolving market. The firm recognizes the significant potential for growth in the psychedelic industry, which has gained traction in recent years due to increased interest and support from diverse stakeholders. Mystic Ventures prioritizes collaboration with dynamic founders and industry experts to validate investment theses and foster the success of its portfolio companies.

Canaccord Genuity is a global independent investment bank headquartered in Toronto, Canada, with a focus on growth companies. It provides a wide range of services, including investment banking, research, sales, trading, and capital markets advisory. The firm specializes in mergers and acquisitions, financial restructuring, and debt advisory, serving institutional and corporate clients across various sectors such as technology, energy, life sciences, and real estate. Canaccord Genuity Wealth Management, a subsidiary of Canaccord Genuity Group Inc., offers comprehensive wealth management solutions and brokerage services tailored to individual investors and private clients. With a presence in multiple countries, the firm is dedicated to identifying investment opportunities and delivering both long-term strategies and near-term solutions to meet the diverse needs of its clients.

MedMen, founded in 2010 and headquartered in Culver City, California, is a leading cannabis company that operates licensed facilities across cultivation, manufacturing, and retail sectors, primarily in California, Nevada, and New York. The company focuses on promoting sensible drug laws that benefit communities and create economic opportunities. MedMen also provides comprehensive services to cannabis license holders, including support in cultivation, extraction, production, and retail operations, applying best practices from institutional frameworks to the cannabis industry. Additionally, through MedMen Capital, the firm strategically invests in key markets throughout the United States and Canada, guiding investors in a sector that has historically lacked institutional presence.

Transnational Cannabis Ltd, formerly ICC International Cannabis Corp is a Canadian company which is engaged in planning, designing, building and operating cannabis production, processing, and distribution facilities. The company through its holdings is engaged in the pharmaceutical distribution, wholesale importation, research, and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the Kingdom of Lesotho, Africa, and Denmark.

Altitude Investment Management, LLC is a New York-based venture capital firm that specializes in investing in the legal cannabis industry. The firm focuses on a range of early-stage to growth-stage companies in North America and Europe. With a team experienced in managing alternative investment funds and navigating highly-regulated industries, Altitude is well-equipped to address the unique regulatory and funding challenges within the cannabis sector. Over the past three years, the firm has developed strong relationships with legal and regulatory professionals, industry executives, and consultants, enhancing its ability to identify and capitalize on investment opportunities in this rapidly expanding market.

Auxly Cannabis Group is a consumer-packaged goods company engaged in the cannabis products market, focusing on the development, manufacturing, and distribution of branded cannabis items. The company operates through two main segments: Canadian cannabis operations and South American cannabis operations. Auxly provides financial solutions to partners looking to build or expand cultivation facilities, enabling them to maintain autonomy while fostering innovation. In return for its support, Auxly receives a small equity stake and rights to a negotiated cultivation yield, allowing partners to accelerate their market entry and enhance their growth potential.

Delta Emerald Ventures is a venture capital firm founded in 2019 and based in New York, New York. The firm focuses on investing in companies within the consumer products, consumer services, healthcare, cannabis, and wellness sectors. Its investment strategy targets opportunities in the United States, Canada, and Europe, aiming to support innovative businesses in these diverse markets.

Silverleaf Venture Partners is a private equity investment manager that invests in the cannabis industry. Silverleaf Venture Partners is an investment manager. For over three decades its founding partners have invested in private equity, real estate and other entrepreneurial investments. Based on their diverse experiences, the managers have honed their styles, skills and structures to minimize downside risk while capturing upside potential. In late summer 2017, the partners identified and recognized the potential of the cannabis industry to achieve outsized growth and made it their primary investment focus. Originally, they invested only their personal capital in nearly a dozen of the industry’s most respected companies. The company was founded in 2017 and based in Stamford, Connecticut.

RA Capital Management, L.P. is a Boston-based venture capital firm that specializes in early and multi-stage investments in the healthcare and life sciences sectors. Founded in 2001, the firm focuses on companies developing drugs, medical devices, diagnostics, and biotechnology. RA Capital invests in a range of funding stages, from seed funding to later rounds, and is known for its willingness to invest under $1 million in initial rounds or larger sums in established companies. The firm's investment strategy emphasizes companies with promising technologies and products, particularly in areas like prevention, cost-effective diagnostics, genetic testing, and personalized medicine. The team consists of professionals with backgrounds in biology, chemistry, and medicine, enabling them to provide valuable insights into data, regulatory processes, and market demands. Additionally, RA Capital often seeks to co-invest and take board positions in its portfolio companies, enhancing their strategic growth opportunities.

JW Asset Management is a New York-based investment firm founded in 1998, specializing in the healthcare sector, among others. The firm operates three hedge funds and two private equity funds, focusing on sector-oriented equity and event-driven investment strategies. Its asset exposure spans equities, derivatives, and both corporate and sovereign fixed income. JW Asset Management is known for its active role in significant transactions, having led the investor group in the acquisition of Arbor Pharmaceuticals, Inc. in 2010 and serving as the lead investor in TerrAscend Corp. Additionally, the firm seeks opportunities within the pharmaceutical, agricultural technology, banking, cannabis, consumer, retail, medical, health, and wellness sectors. As a Registered Investment Adviser, JW Asset Management employs a volatility style preference to guide its investment decisions.

High Tide Inc. is a vertically-integrated company operating in the Canadian cannabis market, specializing in the design, manufacture, and distribution of cannabis accessories and alternative lifestyle products. The company also engages in the retail of cannabis products through its network of retail outlets. As of August 2020, High Tide operated 34 Canna Cabana retail cannabis stores across Ontario, Alberta, and Saskatchewan. Founded in 2009 and headquartered in Calgary, Canada, High Tide has established a diverse portfolio of subsidiaries, including RGR Canada Inc., Smoker's Corner Ltd., Famous Brandz Inc., and a majority stake in KushBar Inc. The company was previously known as High Tide Ventures Inc. before rebranding in October 2018.

Ensemble is a venture capital firm based in San Francisco, California, founded in 2019. The firm focuses on investing in the cannabis ecosystem, serving as a brand accelerator within this market. Ensemble aims to support and enhance the growth of cannabis-related businesses by providing capital and strategic guidance, fostering innovation and development in an evolving industry.

Entourage Effect Capital, established in 2014 and based in Dallas, Texas, is a private investment firm focused on the cannabis industry. The firm aims to identify, invest in, and accelerate high-quality emerging growth companies within this sector. Entourage Effect Capital distinguishes itself by actively engaging with the management teams of its portfolio companies to enhance their value. The firm operates a private equity growth and expansion fund that targets investments in various areas, including cannabis, bioscience, consumer packaged goods, and biotechnology. By leveraging its sector expertise and extensive networks, the firm seeks to create strategic opportunities for early-stage companies, emphasizing a collaborative approach that mirrors the synergistic benefits of the cannabis plant's compounds, known as the "Entourage Effect." This methodology underlines the firm's commitment to maximizing the potential of its investments while supporting the growth of its founders' ventures.

Founded in 2019, Btomorrow Ventures is the corporate venture capital arm of British American Tobacco based in London, United Kingdom. The firm seeks to invest in health and wellness, functional products, science, sustainability, and technology sectors.

Halley Venture Fund I is a venture capital fund managed by Halley Venture Partners, a firm established in 2017 and based in Lafayette, California. The fund specializes in early-stage investments, primarily targeting the legal cannabis industry. It focuses on cannabis-related technology and agricultural companies, aiming to support ancillary businesses that enhance licensed cannabis operations. The firm seeks to invest in companies that can improve sales, innovate products, reduce operational costs, ensure regulatory compliance, and explore the medical applications of cannabis and hemp. Halley Venture Partners comprises a diverse team of professionals, including engineers, scientists, and industry experts, all dedicated to identifying and nurturing the next generation of leading companies in the cannabis sector.

Trulieve is a vertically integrated medical marijuana company that specializes in the cultivation, distribution, and sale of medical cannabis products. The organization is dedicated to providing patients with reliable relief through hand-grown plants cultivated in controlled environments designed to minimize unwanted chemicals and pests. Trulieve's operations encompass the entire process from seed to sale, ensuring that all products meet regulatory standards and patient needs. By focusing on quality and safety, Trulieve aims to establish trust with its consumers while contributing to the evolving landscape of medical marijuana.

Key Investment Partners, founded in 2018 and based in Denver, Colorado, is a venture capital firm that specializes in investments within the cannabis sector. Co-founded by Pete Karabas, Tiby Erdely, and Jordan Youkilis, the firm utilizes a systematic approach to screen, conduct due diligence, and execute investments in high-growth cannabis companies led by strong management teams. Key Investment Partners focuses on various sub-sectors, including business-to-business e-commerce, cannabis testing labs, data analytics, compliance software, and branded products. The firm manages multiple funds, including its 2020 and 2023 vintage funds, and aims to invest in both established and emerging companies across different stages of development, emphasizing opportunities that align with market trends and the evolving cannabis landscape.

Tress Capital, LLC is a private equity firm established in 2013 and based in New York, New York, specializing in the cannabis sector. The firm focuses on various aspects of the industry, including lab testing, biotechnology, media, manufacturing, processing, and cultivation, as well as technology related to both software and hardware. Tress Capital invests globally, targeting regions such as the United States, Africa, the Middle East, Asia Pacific, Europe, and Latin America. The firm employs a dual approach to financing, utilizing both debt and equity to support its investments.

Cresco Labs is a vertically-integrated multi-state cannabis operator based in Chicago, Illinois, founded in 2013. The company is licensed to cultivate, manufacture, and distribute both retail and medical cannabis products. It employs a consumer-packaged-goods approach to its operations, aiming to normalize and professionalize the cannabis industry. Cresco Labs operates its national dispensary brand, Sunnyside, among others, focusing on the comprehensive management of the cannabis supply chain, from cultivation to retail sales.

Jushi Inc. is a vertically integrated cannabis and hemp operator that engages in retail, distribution, cultivation, and processing across both medical and adult-use markets. The company manages a diverse portfolio of branded cannabis and hemp-derived products, developed through strategic acquisitions and competitive applications. Its retail operations include the BEYOND / HELLO brand of cannabis dispensaries, while its hemp-based CBD offerings feature the Nira brand, which encompasses The Lab: Concentrates and The Bank: Flower + Genetics. Additionally, Jushi produces precision-formulated medical cannabis products under the Nira Plus line. The company aims to establish itself as a leader in the cannabis industry.

Acreage Holdings is a New York-based company established in 2011 that operates as a vertically integrated, multi-state owner of cannabis licenses and assets in regions where cannabis is legal for medical and adult use. The company currently operates in 13 states, managing cultivation, processing, and retail dispensary operations, making it one of the largest cannabis companies in the United States. Acreage focuses on producing and selling cannabis and cannabis-infused products, generating revenue primarily through its retail dispensaries. With a commitment to creating a seamless, consumer-focused experience, Acreage Holdings aims to scale its operations and expand its presence across various geographic regions, including New England, the Mid-Atlantic, the Midwest, the West, and the South.

Tuatara Capital, L.P. is a private equity firm established in 2014 and headquartered in New York. The firm specializes in growth equity, buyouts, and late-stage venture investments within the legal cannabis industry in the United States. Tuatara Capital focuses on companies that operate in compliance with U.S. Department of Justice guidelines and seeks to invest across the entire cannabis supply chain, including areas such as cultivation, processing, retail, technology, and industrial services. The firm aims to acquire both minority and majority stakes in market-leading companies that are pivotal in advancing the legal cannabis sector.

12/12 Ventures is a venture capital firm established in 2020 and located in Sausalito, California. The firm specializes in investing in cannabis-focused companies, with a particular emphasis on those operating within the technology sector. By targeting this niche, 12/12 Ventures aims to support the growth and innovation of businesses at the intersection of cannabis and technology.

CordovaCann Corp. is a Canadian cannabis-focused consumer products company based in Toronto. It aims to establish a diversified cannabis business across various U.S. jurisdictions. The company provides services and investment capital to the processing, production, and retail segments of the cannabis industry. As of December 2020, CordovaCann operated four retail stores under the Star Buds brand in Ontario. Originally known as LiveReel Media Corporation, the company rebranded to CordovaCann Corp. in January 2018, reflecting its commitment to the cannabis sector.

IndieBio is an accelerator firm established in 2014 and based in San Francisco, California, with an additional office in New York. It specializes in startups that utilize synthetic biology to address significant global challenges. IndieBio runs four-month accelerator programs aimed at both companies and teams with innovative ideas, focusing on seed-stage and early-stage investments. The firm typically invests $250,000, providing $50,000 in exchange for eight percent equity in biotech startups, with the possibility of an additional $25,000 as a convertible loan note. IndieBio prioritizes investments in businesses that leverage biology as the core of their technology, particularly in life sciences, biotechnology, and related fields. The firm favors teams with a minimum of two co-founders and is open to investing in startups from various geographical locations.

Intrinsic Capital Partners is a venture capital firm based in Conshohocken, Pennsylvania, specializing in growth capital investments primarily within the life sciences and technology sectors of the legal cannabis and hemp markets. Founded in 2000, the firm focuses on promising growth businesses in the emerging legal cannabis industry and leverages a team with extensive experience in investment, pharmaceuticals, regulatory matters, and deal structuring. Intrinsic Capital Partners aims to create value for its portfolio companies while generating superior returns for its investors. The firm also maintains a strong network of operating partners with decades of expertise in building businesses and brands across healthcare and consumer industries, which enhances its investment strategy and execution.

L2 Ventures is a New York-based venture capital firm founded in 2019. The firm specializes in investing in growth-stage companies within the cannabis sector. L2 Ventures focuses on identifying and supporting businesses that are poised for expansion and innovation in this rapidly evolving industry.

Schwazze, formerly known as Medicine Man Technologies, is a cannabis company based in Denver, Colorado, that operates multiple facets of the cannabis industry. The company cultivates, manufactures, and retails a range of cannabis products, including edibles, vape cartridges, and infused products. It owns and operates four dispensaries located in Pueblo, Ordway, Rocky Ford, and Las Animas, providing customers with high-quality cannabis offerings. In addition to retail, Schwazze offers comprehensive consulting services to assist cannabis businesses in navigating state applications, facility design, and operational procedures. The company also produces and supplies plant nutrients, hydroponics, and indoor gardening equipment. Schwazze is committed to supporting clients in the competitive cannabis market, helping them to avoid common pitfalls associated with establishing and operating dispensaries and cultivation facilities.

Cantheon Capital is a private equity firm located in Dallas, Texas, focused on providing financial support to early and mid-stage companies in the biotechnology sector. The firm specializes in assisting businesses that are developing novel FDA-registered pharmaceuticals, particularly in the Cannabinoid and Entheogen space. Cantheon Capital employs various investment strategies, including convertible debt, traditional debt, and growth capital, to help these companies advance through clinical trials and achieve their developmental objectives.

AFI Capital Partners is a growth equity firm established in 2018 and located in Seattle, Washington. The firm specializes in investing in early and growth-stage companies, focusing on opportunities that promise significant potential for expansion and innovation. By providing capital and strategic support, AFI Capital Partners aims to foster the development of its portfolio companies and drive long-term value creation.

Village Farms International is a leading North American producer and marketer of greenhouse-grown vegetables, primarily tomatoes, bell peppers, and cucumbers. The company operates extensive greenhouse facilities in British Columbia and Texas, and it distributes its products under the Village Farms brand to retail supermarkets and fresh food distributors. In addition to its produce business, Village Farms has diversified into the cannabis sector through its subsidiaries, Pure Sunfarms and Balanced Health, which produce and supply cannabis and CBD-based products. The company also operates a power plant that generates electricity, contributing to its energy business. Founded in 1989 and headquartered in Delta, British Columbia, Village Farms International is recognized as one of the largest vertically integrated greenhouse growers in North America.

Supreme Cannabis is a Canada-based company involved in the production and sale of medical and recreational cannabis. Established in 2014, it has rapidly grown into a premium plant-driven lifestyle brand, focusing on disciplined expansion and high-quality offerings. The company's diverse portfolio includes well-known brands such as 7ACRES, which is recognized for its premium cannabis products, as well as BlissCo, Truverra, Sugarleaf, and Hiway. Supreme Cannabis also operates Cambium Plant Sciences, specializing in plant genetics and cultivation intellectual property, and Medigrow Lesotho, a cannabis oil producer in southern Africa. Additionally, it has a brand partnership and licensing arrangement with Khalifa Kush Enterprises Canada, further enhancing its market presence.

WGD Capital is a venture capital firm founded in 2019 and based in San Mateo, California. The firm focuses on investing in early- and expansion-stage private companies, primarily within the cannabis, psychedelics, ag-tech, and health and wellness sectors. WGD Capital manages the WGD Opportunity Fund I, which is specifically dedicated to early-stage investments. The firm seeks opportunities across the United States, Canada, and Israel, aiming to support innovative businesses that are positioned for growth in these emerging markets.

Bonaventure Equity, LLC is a venture capital firm focused on providing growth capital to innovative cannabis companies that offer economic, societal, cultural, and healthcare benefits through advanced technologies and services. Established in 2014, the firm is headquartered in West Palm Beach, Florida, with an additional office in Jupiter, Florida. Bonaventure Equity primarily targets investments in the cannabis sector but also explores opportunities in healthcare, agriculture, advanced manufacturing, food technology, life sciences, health technology, and digital health across the United States. The firm aims to support the development of next-generation solutions that positively impact various industries and communities.

The Arcview Group, founded in 2009 and based in San Francisco, California, is an investment and research company focused on the cannabis industry. It connects investors with cannabis-related businesses, facilitating financing for startups and projects through its extensive network of members. The company invests in various subsectors, including cultivation, retail, infused products, and ancillary services, with individual investments typically ranging from $50,000 to $250,000. Additionally, Arcview hosts webinars and provides resources to help entrepreneurs raise capital and navigate the legal cannabis landscape. Their initiatives, such as the Arcview Angel Network and the MyDispensary Mobile App, aim to support the growth of the cannabis sector by addressing the needs of cultivators, dispensaries, and consumers.

1933 Industries Inc. is a vertically integrated cannabis company based in Vancouver, Canada, that specializes in the cultivation and production of both medical and recreational cannabis. The company operates through two primary segments: AMA, which focuses on the cultivation and sale of cannabis products, and Infused MFG, dedicated to manufacturing hemp-derived CBD products. 1933 Industries offers a diverse range of consumer-branded goods, including tinctures, lotions, vape pens, and concentrates under various brands such as Canna Hemp and Canna Fused. Founded in 2008 and rebranded in 2018, the company controls all aspects of its value chain, from cultivation to extraction and manufacturing, generating the majority of its revenue from the AMA segment in the United States.

FSD Pharma, headquartered in Cobourg, Ontario, is a biopharmaceutical company focused on the development of innovative treatments for neuropsychiatric, neurodegenerative, and inflammatory disorders. The company is advancing three clinical candidates, including FSD201, an ultra-micronized palmitoylethanolamide aimed at treating inflammatory diseases, Lucid-Psych for mental health disorders, and Lucid-MS for neurodegenerative conditions. FSD Pharma operates in two main segments: Biopharmaceutical and Strategic Investments. Additionally, the company aims to transform its facility into a leading hydroponic indoor cannabis cultivation center, targeting various legal aspects of the cannabis industry, such as cultivation, processing, manufacturing, and research and development.

Achari Ventures is a New York-based investment firm founded in 2018 that specializes in venture capital investments in the cannabis sector. The firm focuses on supporting cannabis and cannabis-related companies, aiming to capitalize on the growth opportunities within this expanding industry. By targeting a niche market, Achari Ventures seeks to identify and invest in innovative businesses that are poised for success in the evolving landscape of cannabis.

High Times is a prominent online magazine that has been a key source of cannabis-related news and updates since its establishment in 1974. The publication covers a wide range of topics, including cultivation, legalization, entertainment, and culture surrounding cannabis. It has featured notable writers such as Hunter S. Thompson, Truman Capote, Charles Bukowski, and William Burroughs. High Times operates under the Trans-High Corporation and functions as a diversified media and information services entity. Its business model encompasses various segments, including festivals, events, competitions, publishing, print advertising, e-commerce, and licensing and branding, with a significant portion of its revenue generated from the U.S. market.